The improved effects of GAL on DOX-induced cognitive impairment may be related to nAChR activation, where nAChR activation improved recognition memory in Aβ-treated animals and methamphetamine-treated mice [42,43]. The gene discussed is CHRNA4; the disease is Cognitive impairment.